Low-dose decitabine enhances the efficacy of viral cancer vaccines for immunotherapy
Article (January 2024)
The most recent citing publications are shown below. View all 19 publications that cite this research output on Dimensions.
Improving cancer immunotherapy by rationally combining oncolytic virus with modulators targeting key signaling pathways
Article in Molecular Cancer (October 2022)
Virally programmed extracellular vesicles sensitize cancer cells to oncolytic virus and small molecule therapy
Article in Nature Communications (April 2022)